Lea R. Gordon

470 total citations
15 papers, 336 citations indexed

About

Lea R. Gordon is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lea R. Gordon has authored 15 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lea R. Gordon's work include Veterinary Medicine and Surgery (2 papers), Hormonal and reproductive studies (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Lea R. Gordon is often cited by papers focused on Veterinary Medicine and Surgery (2 papers), Hormonal and reproductive studies (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Lea R. Gordon collaborates with scholars based in United States, France and Switzerland. Lea R. Gordon's co-authors include Keith A. Soper, J. R. Brooks, G. F. REYNOLDS, R. L. Primka, Gary H. Rasmusson, L. David Wise, Richard E. Morrissey, C. P. Peter, S. Prahalada and David M. Berman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Lea R. Gordon

15 papers receiving 311 citations

Peers

Lea R. Gordon
B. A. J. EVANS United Kingdom
G D'Eramo Italy
Henry J. Johnson United States
Wun Jae Kim South Korea
D. E. Prentice United Kingdom
Xiangmin Zhao United States
B. A. J. EVANS United Kingdom
Lea R. Gordon
Citations per year, relative to Lea R. Gordon Lea R. Gordon (= 1×) peers B. A. J. EVANS

Countries citing papers authored by Lea R. Gordon

Since Specialization
Citations

This map shows the geographic impact of Lea R. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea R. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea R. Gordon more than expected).

Fields of papers citing papers by Lea R. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea R. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea R. Gordon. The network helps show where Lea R. Gordon may publish in the future.

Co-authorship network of co-authors of Lea R. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Lea R. Gordon. A scholar is included among the top collaborators of Lea R. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea R. Gordon. Lea R. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Britten, Carolyn D., Mark D. Pegram, Philip Rosen, et al.. (2004). Targeting ErbB receptor interactions: A phase I trial of trastuzumab and erlotinib in metastatic HER2+ Breast Cancer. Journal of Clinical Oncology. 22(14_suppl). 3045–3045. 13 indexed citations
2.
Gordon, Lea R., et al.. (1997). Preclinical Ocular Irritation Findings with Dorzolamide Hydrochloride. Journal of Toxicology Cutaneous and Ocular Toxicology. 16(1). 9–17. 5 indexed citations
3.
Storer, Richard D., et al.. (1996). Rapid Induction of Hyperplasiain Vitroin Rat Bladder Explants by Elevated Sodium Ion Concentrations and Alkaline pH. Toxicology and Applied Pharmacology. 138(2). 219–230. 5 indexed citations
4.
Gordon, Lea R., et al.. (1996). Evaluating Delayed Contact Hypersensitivity Reactions from Ocular Medications. Journal of Toxicology Cutaneous and Ocular Toxicology. 15(3). 235–248. 2 indexed citations
5.
Wise, L. David, et al.. (1995). Developmental neurotoxicity evaluation of acrylamide in Sprague-Dawley rats. Neurotoxicology and Teratology. 17(2). 189–198. 61 indexed citations
6.
Gordon, Lea R., et al.. (1995). Cross Sensitivity Reactions Among Carbonic Anhydrase Inhibitors in the Guinea Pig. Journal of Toxicology Cutaneous and Ocular Toxicology. 14(2). 63–73. 1 indexed citations
7.
Prahalada, S., Lea R. Gordon, Walter Bagdon, et al.. (1994). Effects of chronic oral administration of a selective 5α‐reductase inhibitor, finasteride, on the dog prostate. The Prostate. 24(2). 93–100. 39 indexed citations
8.
Shivaprasad, H. L., John P. Sundberg, Kathleen Mc Entee, et al.. (1994). Cystic Adenomatous Hyperplasia of the Equine Allantois: A Report of Eight Cases. Journal of Veterinary Diagnostic Investigation. 6(1). 107–110. 9 indexed citations
9.
Prahalada, S., Kevin P. Keenan, Lea R. Gordon, et al.. (1994). Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor. Urology. 43(5). 680–685. 32 indexed citations
10.
Owen, Robin, et al.. (1993). Renal Papillary Cytoplasmic Granularity and Potassium Depletion Induced by Carbonic Anhydrase Inhibitors in Rats. Toxicologic Pathology. 21(5). 449–455. 3 indexed citations
11.
Crouch, Louis S., Lea R. Gordon, William F. Feely, et al.. (1992). Nontoxicity of polar abamectin degradates from citrus fruit and thin film photolysis. Journal of Agricultural and Food Chemistry. 40(1). 88–92. 6 indexed citations
12.
Smith, Peter F., Scott Grossman, Ronald J. Gerson, et al.. (1991). Studies on the Mechanism of Simvastatin-Induced Thyroid Hypertrophy and Follicular Cell Adenoma in the Rat. Toxicologic Pathology. 19(3). 197–205. 37 indexed citations
13.
Brooks, J. R., Charles L. Berman, David M. Giltinan, et al.. (1986). Prostatic effects induced in dogs by chronic or acute oral administration of 5α‐reductase inhibitors. The Prostate. 9(1). 65–75. 60 indexed citations
14.
Gordon, Lea R.. (1986). Spontaneous Lipomatous Tumors in the Kidney of the Crl:CD(SD)BR Rat. Toxicologic Pathology. 14(2). 175–182. 4 indexed citations
15.
Brooks, J. R., David M. Berman, M. S. Glitzer, et al.. (1982). Effect of a new 5α‐reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate. The Prostate. 3(1). 35–44. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026